Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The target "Multiple endogenous receptors and extracellular proteins involved in corneal repair" refers to the integrated network of signaling molecules and structural components that coordinate the healing of the corneal epithelium and stroma. This complex system includes various growth factors (such as EGF, NGF, and TGF-beta), their corresponding cell-surface receptors (such as EGFR and TrkA), and extracellular matrix (ECM) proteins (such as collagen, fibronectin, and heparan sulfate) that provide the necessary scaffold for cell migration and proliferation. In chronic conditions like neurotrophic keratitis or persistent corneal ulcers, the natural balance of these components is often disrupted by excessive proteolytic activity, which degrades the matrix and signaling molecules. Therapeutic agents like ReGeneraTing Agents (RGTAs), specifically Cacicol, act by mimicking heparan sulfate to bind and protect these endogenous factors from degradation, thereby restoring the regenerative microenvironment. Other therapies may specifically target individual receptors within this network, such as Cenegermin (rhNGF) for TrkA, or inhibit pathological processes like inflammation and gap junction communication (e.g., Connexin 43). This multi-component approach is essential for treating severe corneal injuries where standard lubrication and anti-inflammatory treatments are insufficient to promote tissue closure.
The mechanism involves mimicking heparan sulfate to protect endogenous growth factors and extracellular matrix (ECM) proteins from proteolytic degradation (e.g., RGTAs like Cacicol), activating specific neurotrophic receptors (e.g., Cenegermin for TrkA), or inhibiting pathological mediators such as TRPV1, Connexin 43, and matrix metalloproteinases (MMPs) to restore the corneal microenvironment.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple endogenous receptors and extracellular proteins involved in corneal repair.